Decreased Intrathecal Concentrations of Free Light Chains Kappa in Multiple Sclerosis Patients Taking Very High Effective Disease-Modifying Treatment.

Süße, Marie; Konen, Franz Felix; Schwenkenbecher, Philipp; Budde, Kathrin; Nauck, Matthias; Grothe, Matthias; Hannich, Malte Johannes; Skripuletz, Thomas

Süße, Marie; Konen, Franz Felix; Schwenkenbecher, Philipp; Budde, Kathrin; Nauck, Matthias; Grothe, Matthias; Hannich, Malte Johannes; Skripuletz, Thomas.

Afiliação

Süße M; Department of Neurology, University Medicine Greifswald, 17475 Greifswald, Germany.
Konen FF; Department of Neurology, Hannover Medical School, 30625 Hannover, Germany.
Schwenkenbecher P; Department of Neurology, Hannover Medical School, 30625 Hannover, Germany.
Budde K; Institute of Clinical Chemistry and Laboratory Medicine, University Medicine Greifswald, 17475 Greifswald, Germany.
Nauck M; Institute of Clinical Chemistry and Laboratory Medicine, University Medicine Greifswald, 17475 Greifswald, Germany.
Grothe M; Department of Neurology, University Medicine Greifswald, 17475 Greifswald, Germany.
Hannich MJ; Institute of Clinical Chemistry and Laboratory Medicine, University Medicine Greifswald, 17475 Greifswald, Germany.
Skripuletz T; Department of Neurology, Hannover Medical School, 30625 Hannover, Germany.

Diagnostics (Basel) ; 12(3)2022 Mar 16.

Article em En | MEDLINE | ID: mdl-35328273

Palavras-chave

cerebrospinal fluid; disease-modifying therapy; free light chain kappa; immunoglobulin synthesis; multiple sclerosis; oligoclonal IgG

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Observational_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Observational_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article